These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20589994)

  • 1. Interview with Marc Ferrer, Ph.D.. Interview by Vicki Glaser.
    Ferrer M
    Assay Drug Dev Technol; 2010 Jun; 8(3):263-7. PubMed ID: 20589994
    [No Abstract]   [Full Text] [Related]  

  • 2. An interview with Paul England, Ph.D., ProXara Biotechnology, Ltd. Interviewed by Vicki Glaser.
    England P
    Assay Drug Dev Technol; 2004 Apr; 2(2):115-20. PubMed ID: 15165507
    [No Abstract]   [Full Text] [Related]  

  • 3. An interview with Peter J. Coassin. Interview by Vicki Glaser.
    Coassin PJ
    Assay Drug Dev Technol; 2005 Apr; 3(2):125-31. PubMed ID: 15871687
    [No Abstract]   [Full Text] [Related]  

  • 4. An interview with Kenneth C. Lewis, Ph.D., CEO, and Joseph D. Simpkins, Vice President, Software, OpAns (Optimized Analytical Solutions), Durham, NC. Interview by Vicki Glaser.
    Lewis KC; Simpkins JD
    Assay Drug Dev Technol; 2007 Dec; 5(6):695-702. PubMed ID: 18181688
    [No Abstract]   [Full Text] [Related]  

  • 5. The business of RNAi therapeutics.
    Haussecker D
    Hum Gene Ther; 2008 May; 19(5):451-62. PubMed ID: 18435603
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic possibilities of interference RNA.
    López Tricas JM
    Farm Hosp; 2012; 36(3):115-7. PubMed ID: 22137610
    [No Abstract]   [Full Text] [Related]  

  • 7. Interview with Thomas P. Monath, M.D. Interview by Vicki Glaser.
    Monath TP
    Vector Borne Zoonotic Dis; 2005; 5(3):300-4. PubMed ID: 16187902
    [No Abstract]   [Full Text] [Related]  

  • 8. An interview with Hakim Djaballah, Ph.D. Interview by Vicki Glaser.
    Djaballah H
    Assay Drug Dev Technol; 2010 Oct; 8(5):519-25. PubMed ID: 20973720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Interview with Jesús "Tito" González, Ph.D., Senior Director, Biology, Vertex Pharmaceuticals, San Diego, CA: interviewed by Vicki Glaser.
    Gonzalez J
    Assay Drug Dev Technol; 2008 Apr; 6(2):143-7. PubMed ID: 18471072
    [No Abstract]   [Full Text] [Related]  

  • 10. RNA interference: the silent treatment.
    Clayton J
    Nature; 2004 Sep; 431(7008):599-605. PubMed ID: 15457267
    [No Abstract]   [Full Text] [Related]  

  • 11. An interview with Lars J. Brandén, Ph.D. Associate director for Chemical Genetics, Judith P. Sulzberger Genome Center, Columbia University, New York. Interview by Vicki Glaser.
    Brandén LJ
    Assay Drug Dev Technol; 2007 Aug; 5(4):465-71. PubMed ID: 17767415
    [No Abstract]   [Full Text] [Related]  

  • 12. An interview with Steven M. Watkins, Ph.D., president and chief scientific officer, Lipomics Technologies, Inc. Interview by Vicki Glaser.
    Watkins SM
    Assay Drug Dev Technol; 2004 Aug; 2(4):339-43. PubMed ID: 15357914
    [No Abstract]   [Full Text] [Related]  

  • 13. An interview with Ken Valenzano, Ph.D. Interview by Vicki Glaser.
    Valenzano KJ
    Assay Drug Dev Technol; 2011 Jun; 9(3):191-7. PubMed ID: 21612548
    [No Abstract]   [Full Text] [Related]  

  • 14. An interview with Martin Rosenberg, Ph.D. Interviewed by Vicki Glaser.
    Rosenberg M
    Assay Drug Dev Technol; 2009 Dec; 7(6):537-43. PubMed ID: 20035618
    [No Abstract]   [Full Text] [Related]  

  • 15. An interview with Doriano Fabbro, Ph.D., Novartis Biomedical Research Institute. Interviewed by Vicki Glaser.
    Fabbro D
    Assay Drug Dev Technol; 2004 Apr; 2(2):109-14. PubMed ID: 15165506
    [No Abstract]   [Full Text] [Related]  

  • 16. Companies jostle for lead in RNAi, despite uncertainties.
    Osborne R
    Nat Biotechnol; 2007 Nov; 25(11):1191-2. PubMed ID: 17989654
    [No Abstract]   [Full Text] [Related]  

  • 17. Unlocking the money-making potential of RNAi.
    Howard K
    Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Protein-protein interactions, biomarkers and RNAi.
    Pagliaro L
    IDrugs; 2005 Oct; 8(10):793-5. PubMed ID: 16254793
    [No Abstract]   [Full Text] [Related]  

  • 19. [Strathmann AG: first OTC, now biotechnology. AIDS vaccines from German biotechnology research? (interview by Dr. med. Dirk Einecke)].
    Strathmann G
    MMW Fortschr Med; 2001 Oct; 143(42):58-9. PubMed ID: 11697293
    [No Abstract]   [Full Text] [Related]  

  • 20. Interview with John W. Kozarich, PhD. Interview by Vicki Glaser.
    Kozarich JW
    Assay Drug Dev Technol; 2013 Jun; 11(5):283-8. PubMed ID: 23772549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.